MHRA: Human Medicines Wholesale Distribution Sites Register for Due Diligence

• The MHRA and Department of Health and Social Care jointly maintain a computerised register of all UK licensed wholesale dealers of human medicines.
• This MHRA human medicines wholesale distribution sites register provides unique licence and site numbers for each authorised entity.
• Legal and compliance professionals should regularly consult this register for due diligence and to ensure adherence to MHRA Good Distribution Practice (GDP) compliance.
• The register's data is published in CSV files, including a key for interpretation, and is also available on MHRA-GMDP.
• The MHRA updates this essential regulatory resource on a monthly basis, reflecting the most current information held by the agency.

Legal and compliance professionals operating within the pharmaceutical sector must regularly consult this official Medicines and Healthcare products Regulatory Agency register to ensure their organisations and partners adhere to stringent UK human medicine distribution regulations.

The Medicines and Healthcare products Regulatory Agency (MHRA), in conjunction with the Department of Health and Social Care, maintains a crucial public register detailing all UK licensed wholesale dealers of human medicines. This comprehensive database, known as the MHRA human medicines wholesale distribution sites register, serves as a central repository of information for entities authorised to distribute human medicinal products across the United Kingdom. It is a fundamental component of ensuring the integrity and safety of the human medicines supply chain UK.

Each entry within this computerised register provides specific identifiers: a unique licence number assigned to the company holding the authorisation, and a distinct site number for each individual distribution location. This granular detail allows for precise identification and verification of legitimate operators within the pharmaceutical distribution network. The information made publicly available accurately reflects the data held by the MHRA at the exact moment of its publication, ensuring current regulatory oversight.

For legal and compliance professionals operating within the pharmaceutical sector, the MHRA human medicines wholesale distribution sites register is an indispensable resource. Regularly consulting this official Medicines and Healthcare products Regulatory Agency register is vital for conducting thorough due diligence and verifying the legitimacy of trading partners. It enables organisations to confirm that their collaborators possess the necessary Wholesale Distribution Authorisation (WDA) register GB entries, thereby upholding MHRA Good Distribution Practice (GDP) compliance standards.

Adherence to these regulations is paramount for maintaining the safety and quality of medicines reaching patients. By cross-referencing potential or existing partners against this official list, companies can mitigate risks associated with unauthorised distribution and ensure their operations remain fully compliant with UK human medicine distribution regulations. This proactive approach is a cornerstone of responsible pharmaceutical business practices.

The information contained within the MHRA human medicines wholesale distribution sites register is made available in a structured format, typically as CSV files. For instance, the September 2026 version of the register is a CSV file approximately 1.53 MB in size. To aid users in navigating and understanding the data, a separate 'Key for human files' is also provided, a smaller CSV file weighing around 1.91 KB.

It is important for users to note that while these files offer comprehensive data, they may not be optimally suited for individuals relying on assistive technology. Beyond the direct downloads, the same information is also accessible via the MHRA-GMDP platform, offering an alternative avenue for accessing the latest regulatory data on licensed wholesale distribution sites.

The MHRA demonstrates a consistent commitment to maintaining the currency and accuracy of its human medicines wholesale distribution sites register. The register undergoes monthly updates, ensuring that the published data reflects the most recent regulatory landscape. This frequent refresh cycle is critical given the dynamic nature of the pharmaceutical industry and the ongoing changes in licensed entities.

Historical records illustrate this regular cadence, with updates consistently published for months such as September 2026, August 2026, July 2026, and extending back through December 2025, November 2024, and October 2024. While the primary focus is on human medicines, some updates have also included information pertaining to licensed wholesale distribution sites for veterinary products, further underscoring the comprehensive nature of the MHRA's regulatory oversight.

Lawyers and compliance officers in the pharmaceutical sector should regularly consult the updated MHRA register of licensed wholesale distribution sites to ensure their clients or organisations are dealing with authorised entities and to maintain compliance with UK human medicine distribution regulations. This resource is crucial for due diligence and verifying the legitimacy of trading partners.

Source: Original reporting via UK government publications